475 assets in Plasma Cell Myeloma

Therapeutic assets addressing Plasma Cell Myeloma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
ct0591cp cells Plasma Cell Myeloma	The First Affiliated Hospital of Soochow University	Early P1	C (39)
Dickkopf-Related Protein 1 Plasma Cell Myeloma	Case Comprehensive Cancer Center	Early P1	C (39)
ft576 Plasma Cell Myeloma	Fate Therapeutics	P1	C (39)
Iaso104 Plasma Cell Myeloma	Institute of Hematology & Blood Diseases Hospital, China	Early P1	C (39)
Mirdametinib Plasma Cell Myeloma	National Cancer Institute (NCI)	P1/2	C (39)
Noraramtide Plasma Cell Myeloma	Biohaven Pharmaceuticals, Inc.	P1	C (39)
Telaglenastat Plasma Cell Myeloma	National Cancer Institute (NCI)	P1	C (39)
Xmab24306 Plasma Cell Myeloma	Genentech, Inc.	P1	C (39)
Zelavespib I-124 Plasma Cell Myeloma	Memorial Sloan Kettering Cancer Center	Early P1	C (39)
imv102 treatment Plasma Cell Myeloma	Suzhou Immunofoco Biotechnology Co., Ltd	Early P1	C (38)
Metabolically Armed Bcma Car-T Cells. Plasma Cell Myeloma	Anhui Provincial Hospital	Early P1	C (38)
Oriv508 Plasma Cell Myeloma	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Early P1	C (38)
Vactosertib Plasma Cell Myeloma	David Wald	P1	C (37)
3d189 Plasma Cell Myeloma	3D Medicines	P1	C (36)
Abbv-438 Plasma Cell Myeloma	AbbVie	P1	C (36)
anv419 Plasma Cell Myeloma	Anaveon AG	P1	C (36)
Astatine At 211 Anti-Cd38 Monoclonal Antibody Okt10-B10 Plasma Cell Myeloma	Fred Hutchinson Cancer Center	P1	C (36)
Bcma Car T Cells Plasma Cell Myeloma	University College, London	P1	C (36)
Bl-M24D1 Plasma Cell Myeloma	Sichuan Baili Pharmaceutical Co., Ltd.	P1	C (36)
Bms-986453 Plasma Cell Myeloma	Susan Bal	P1	C (36)
car138 t cells Plasma Cell Myeloma	UNC Lineberger Comprehensive Cancer Center	P1	C (36)
cd19-ucart Plasma Cell Myeloma	Anhui Provincial Hospital	P1	C (36)
Cxcr4 Modified Anti-Bcma Car T Cells Plasma Cell Myeloma	Sichuan University	P1	C (36)
Descartes-25 Plasma Cell Myeloma	Cartesian Therapeutics	P1	C (36)
Efineptakin Alfa Plasma Cell Myeloma	Washington University School of Medicine	P1	C (36)
Egfrt/Bcma-41Bbz Car T Cell Plasma Cell Myeloma	Memorial Sloan Kettering Cancer Center	P1	C (36)
Fhnd6091 Plasma Cell Myeloma	Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.	P1	C (36)
Fianlimab Plasma Cell Myeloma	Regeneron Pharmaceuticals	P1	C (36)
Gintemetostat Plasma Cell Myeloma	K36 Therapeutics, Inc.	P1	C (36)
Icovamenib Plasma Cell Myeloma	Biomea Fusion Inc.	P1	C (36)
Igm-2644 Plasma Cell Myeloma	IGM Biosciences, Inc.	P1	C (36)
Immunoglobulin G1 [De-451-Lysine], Anti-(Human/Macaca Fascicularis/Macaca Mulatta/Chlorocebus Sabaeus Mhc Class I Chain-Related Protein Mica/Mhc Class I Chain-Related Protein Micb) (Human-Mus Musculus Monoclonal Cln-619 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Cln-619 [34-Leucine] ?-Chain, Dimer Plasma Cell Myeloma	Cullinan Therapeutics Inc.	P1	C (36)
Ingitamig Plasma Cell Myeloma	Celgene	P1	C (36)
Ksvcbd Plasma Cell Myeloma	Chinese PLA General Hospital	P1	C (36)
Loxo-338 Plasma Cell Myeloma	Eli Lilly and Company	P1	C (36)
lp-118 Plasma Cell Myeloma	Newave Pharmaceutical Inc	P1	C (36)
Mcarh109 Plasma Cell Myeloma	Memorial Sloan Kettering Cancer Center	P1	C (36)
Mcarh125 Plasma Cell Myeloma	Memorial Sloan Kettering Cancer Center	P1	C (36)
Nex-20A Plasma Cell Myeloma	Nanexa AB	Early P1	C (36)
Nms-03597812 Plasma Cell Myeloma	Nerviano Medical Sciences	P1	C (36)
OL-101 Plasma Cell Myeloma	Zhejiang University	P1	C (36)
Oric321 Plasma Cell Myeloma	Zhejiang University	P1	C (36)
P-Bcma-Allo1 Car-T Cells Plasma Cell Myeloma	Poseida Therapeutics, Inc.	P1	C (36)
Pirtobrutinib Plasma Cell Myeloma	Eli Lilly and Company	P1	C (36)
Recombinant Fully Human Igg1 Kappa Anti-Tigit Monoclonal Antibody Eos-448 Plasma Cell Myeloma	iTeos Therapeutics	P1	C (36)
Recombinant Glycosylated Human Interleukin-7 Plasma Cell Myeloma	Washington University School of Medicine	P1	C (36)
Romosozumab Plasma Cell Myeloma	Memorial Sloan Kettering Cancer Center	P1	C (36)
Shr-3836 Administered As Multiple Doses. Plasma Cell Myeloma	Shanghai Hengrui Pharmaceutical Co., Ltd.	P1	C (36)
Shr-9539 For Plasma Cell Myeloma	Suzhou Suncadia Biopharmaceuticals Co., Ltd.	P1	C (36)
Sotatercept Plasma Cell Myeloma	Rebecca Silbermann	P2	C (36)

Showing 351 to 400 of 474 assets

PreviousPage 8 of 10Next